Come to BioSquare and meet with world class companies on Feb 1st and 2d in Geneva- Switzerland:

Abbott - Bayer Schering Pharma - Biogen Idec -Bristol Myers Squibb -
Burrill & Company - Chiesi - Crucell - Debiopharm - Eli Lilly & Co - Galderma- Genentech -Genzyme - GlaxoSmithKline - Grunenthal - Johnson & Johnson - Lonza -
Merck Serono - Merck & Co- Nycomed - Novartis - Philips Healthcare - Roche
Sanofi Aventis - Sanofi Pasteur - SkyePharma AG - Solvay Pharmaceuticals
Teva Pharmaceutical -Transgene...

Strong delegations of companies from China, Brazil and Israel will also be attending!

BioSquare Keynote Speakers

* Patrick Aebischer, President, Ecole Polytechnique de Lausanne (EPFL)
* Humberto Antunes, CEO, Galderma
* G. Steven Burrill, CEO, Burrill & Company
* Jose Angel Cordova, Secretary of Health, Mexico (TBC)
* Matthias Fehr, HBM Partners, Investment Advisor Public Equity Team
* Pascal Frank, Biotech and Pharma analyst, Pictet & Cie
* Jaap Goudsmit, CSO, Crucell
* Jackie Hunter, SVP, GlaxoSmithKline
* Ronald Kent, Executive Vice President, Euronext
* Delphine Le Louët, Pharma analyst, Lombard Odier
* Michael Lytton, Ex. VP, Business and Corporate Development, Biogen Idec
* James Geraghty, Senior VP, Genzyme
* Bernard Munos, Advisor, Corporate Strategy, Eli Lilly and Company
* Francesco de Rubertis, Partner, Index Ventures
* Elmar Schnee, President, Merck Serono
* Michael Sjöström, Chief Investment Officer, Sectoral Asset Management
* Paul Stoffels, Global Head, R&D, Johnson and Johnson
* Christopher A. Viehbacher, CEO, Sanofi-aventis
* Hongguang Wang, Director General, China National Center for Biotechnology Development


For more information and to register, please log on to www.biosquare.com